Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 4:33 pm Purchase | 2021-12-31 | 13G | Acorda Therapeutics, Inc. ACOR | Point72 Asset Management, L.P. | 23,214 4.100% | 23,214 (New Position) | Filing History |
| 2022-02-14 4:32 pm Purchase | 2021-12-31 | 13G | Viridian Therapeutics, Inc. VRDN | Point72 Asset Management, L.P. | 472,864 2.200% | 46,702 (+10.96%) | Filing History |
| 2022-02-14 4:32 pm Sale | 2021-12-31 | 13G | Golar LNG Limited GLNG | Point72 Asset Management, L.P. | 4,406,367 4.100% | -1,174,969 (-21.05%) | Filing History |
| 2022-02-14 4:31 pm Unchanged | 2021-12-31 | 13G | Bakkt Holdings, Inc. BKKT | Point72 Asset Management, L.P. | 0 0.000% | 0 (Unchanged) | Filing History |
| 2022-02-14 4:31 pm Sale | 2021-12-31 | 13G | Forte Biosciences, Inc. FBRX | Point72 Asset Management, L.P. | 44 0.100% | -27,798 (-99.84%) | Filing History |
| 2022-02-14 4:29 pm Purchase | 2021-12-31 | 13G | Avalo Therapeutics, Inc. AVTX | Point72 Asset Management, L.P. | 2,088 5.400% | 1 (+0.05%) | Filing History |
| 2022-02-14 4:28 pm Purchase | 2021-12-31 | 13G | Atara Biotherapeutics, Inc. ATRA | Point72 Asset Management, L.P. | 185,366 5.200% | 2,645 (+1.45%) | Filing History |
| 2022-02-14 4:27 pm Purchase | 2021-12-31 | 13G | Arcutis Biotherapeutics, Inc. ARQT | Point72 Asset Management, L.P. | 2,657,962 5.300% | 107,226 (+4.20%) | Filing History |
| 2022-02-14 4:26 pm Purchase | 2021-12-31 | 13G | Akero Therapeutics, Inc. AKRO | Point72 Asset Management, L.P. | 1,760,248 5.000% | 8,685 (+0.50%) | Filing History |
| 2022-02-14 4:25 pm Sale | 2021-12-31 | 13G | Aeglea BioTherapeutics, Inc. AGLE | Point72 Asset Management, L.P. | 2,244 0.100% | -114,948 (-98.09%) | Filing History |
| 2022-02-11 5:05 pm Purchase | 2022-02-01 | 13G | uniQure N.V. QURE | Point72 Asset Management, L.P. | 3,611,691 7.800% | 3,143,854 (+672.00%) | Filing History |
| 2022-02-10 5:07 pm Purchase | 2022-01-31 | 13G | FibroGen, Inc. FGEN | Point72 Asset Management, L.P. | 186,644 5.000% | 186,644 (New Position) | Filing History |
| 2022-01-10 4:52 pm Purchase | 2022-01-07 | 13G | BellRing Brands, Inc. BRBR | Point72 Asset Management, L.P. | 1,983,182 5.100% | 1,983,182 (New Position) | Filing History |
| 2022-01-04 5:20 pm Purchase | 2022-01-03 | 13G | Applied Therapeutics, Inc. APLT | Point72 Asset Management, L.P. | 2,556,976 9.800% | 2,556,976 (New Position) | Filing History |
| 2021-12-21 5:13 pm Purchase | 2021-12-20 | 13G | Atara Biotherapeutics, Inc. ATRA | Point72 Asset Management, L.P. | 182,721 5.200% | 182,721 (New Position) | Filing History |
| 2021-12-15 5:14 pm Purchase | 2021-12-14 | 13G | Arcutis Biotherapeutics, Inc. ARQT | Point72 Asset Management, L.P. | 2,550,736 5.100% | 2,550,736 (New Position) | Filing History |
| 2021-12-13 4:58 pm Purchase | 2021-12-10 | 13G | Akero Therapeutics, Inc. AKRO | Point72 Asset Management, L.P. | 1,751,563 5.000% | 1,751,563 (New Position) | Filing History |
| 2021-12-06 5:22 pm Purchase | 2021-12-03 | 13G | Krystal Biotech, Inc. KRYS | Point72 Asset Management, L.P. | 1,343,242 5.400% | 1,343,242 (New Position) | Filing History |
| 2021-11-17 5:27 pm Purchase | 2021-11-09 | 13G | X4 Pharmaceuticals, Inc. XFOR | Point72 Asset Management, L.P. | 50,008 5.600% | 50,008 (New Position) | Filing History |
| 2021-10-28 5:24 pm Purchase | 2021-10-27 | 13G | Xenon Pharmaceuticals Inc. XENE | Point72 Asset Management, L.P. | 2,641,253 5.100% | 2,641,253 (New Position) | Filing History |